Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2016 May 25:11:1077-85.
doi: 10.2147/COPD.S104616. eCollection 2016.

Nasal highflow improves ventilation in patients with COPD

Affiliations
Clinical Trial

Nasal highflow improves ventilation in patients with COPD

Jens Bräunlich et al. Int J Chron Obstruct Pulmon Dis. .

Abstract

Background: Nasal highflow (NHF) provides a warmed and humidified air stream up to 60 L/min. Recent data demonstrated a positive effect in patients with acute hypoxemic respiratory failure, especially when caused by pneumonia. Preliminary data show a decrease in hypercapnia in patients with COPD. Therefore, NHF should be evaluated as a new ventilatory support device. This study was conducted to assess the impact of different flow rates on ventilatory parameters in patients with COPD.

Materials and methods: This interventional clinical study was performed with patients suffering from severe COPD. The aim was to characterize flow-dependent changes in mean airway pressure, breathing volumes, breathing frequency, and decrease in partial pressure of CO2 (pCO2). Mean airway pressure was measured in the nasopharyngeal space (19 patients). To evaluate breathing volumes, we used a polysomnographic device (18 patients). All patients received 20 L/min, 30 L/min, 40 L/min, and 50 L/min and - to illustrate the effects - nasal continuous positive airway pressure and nasal bilevel positive airway pressure. Capillary blood gas analyses were performed in 54 patients with hypercapnic COPD before and two hours after the use of NHF. We compared the extent of decrease in pCO2 when using 20 L/min and 30 L/min. Additionally, comfort and dyspnea during the use of NHF were surveyed.

Results: NHF resulted in a minor flow dependent increase in mean airway pressure. Tidal volume increased, and breathing rate decreased. The calculated minute volume decreased under NHF breathing. In spite of this fact, hypercapnia decreased with increasing flow (20 L/min vs 30 L/min). Additionally, an improvement in dyspnea was observed. The rapid shallow breathing index shows a decrease when using NHF.

Conclusion: NHF leads to a flow-dependent reduction in pCO2. This is most likely achieved by a washout of the respiratory tract and a functional reduction in dead space. In summary, NHF enhances effectiveness of breathing in patients with COPD, reduces pCO2, the work of breathing, and rapid shallow breathing index as an indicator of respiratory work load.

Keywords: NHF; hypercapnia; nasal high flow cannula; pCO2; ventilation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Changes in mean airway pressure (n=19, medium prong size). Notes: *Significant P-value and **no significant P-value. Abbreviations: nBiPAP, (nasal) bilevel positive airway pressure; nCPAP, (nasal) continuous positive airway pressure.
Figure 2
Figure 2
Percentage changes in tidal volume (n=18, medium prong size). Notes: *Significant P-value and **no significant P-value. Abbreviations: nBiPAP, (nasal) bilevel positive airway pressure; nCPAP, (nasal) continuous positive airway pressure.
Figure 3
Figure 3
Percentage changes in breathing rate (n=18, medium prong size). Notes: *Significant P-value and **no significant P-value. Abbreviations: nBiPAP, (nasal) bilevel positive airway pressure; nCPAP, (nasal) continuous positive airway pressure.
Figure 4
Figure 4
Percentage changes in minute volume (n=18, medium prong size). Notes: *Significant P-value and **no significant P-value. Abbreviations: nBiPAP, (nasal) bilevel positive airway pressure; nCPAP, (nasal) continuous positive airway pressure.
Figure 5
Figure 5
Percentage changes in RSBI (n=18, medium prong size). Notes: *Significant P-value and **no significant P-value. Abbreviations: nBiPAP, (nasal) bilevel positive airway pressure; nCPAP, (nasal) continuous positive airway pressure; RSBI, rapid shallow breathing index.
Figure 6
Figure 6
Percentage changes in pCO2 after 2 hours of NHF breathing (n=54, medium prong size). Note: *Significant P-value. Abbreviations: NHF, nasal highflow; pCO2, partial pressure of CO2.

Comment in

  • The use of high-flow nasal oxygen in COPD patients.
    Silva Santos P, Esquinas AM. Silva Santos P, et al. Int J Chron Obstruct Pulmon Dis. 2016 Sep 16;11:2259-2260. doi: 10.2147/COPD.S117028. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27695313 Free PMC article. No abstract available.

References

    1. Wijkstra PJ, Lacasse Y, Guyatt GH, Goldstein RS. Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002;3:CD002878. - PubMed
    1. Struik FM, Lacasse Y, Goldstein R, Kerstjens HM, Wijkstra PJ. Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2013;6:CD002878. - PMC - PubMed
    1. Dreher M, Storre JH, Schmoor C, Windisch W. High-intensity versus low-intensity non-invasive ventilation in patients with stable hypercapnic COPD: a randomised crossover trial. Thorax. 2010;65(4):303–308. - PubMed
    1. Windisch W, Haenel M, Storre JH, Dreher M. High-intensity non-invasive positive pressure ventilation for stable hypercapnic COPD. Int J Med Sci. 2009;6(2):72–76. - PMC - PubMed
    1. Köhnlein T, Windisch W, Köhler D, et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med. 2014;2(9):698–705. - PubMed

Publication types

MeSH terms